Skip to content

Evaluation of the clinical efficacy of Yin-Yang regulating moxibustion on the sleep quality of patients with abdominal obesity

Evaluation of the clinical efficacy of Yin-Yang regulating moxibustion on the sleep quality of patients with abdominal obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001162
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity accompanied by sleep quality problems

Interventions

Experimental group:Yin-Yang regulating moxibustion+Basic Intervention

Sponsors

Hubei Provincial Hospital ofTraditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: Aged between 18 and 60 years old; 2: Meeting the diagnostic criteria for abdominal obesity; 3: Consciously having mild or moderate sleep quality problems (such as having symptoms like sleep duration less than 6 hours waking up frequently more than 3 times at night feeling fatigued and having inattentiveness during the day etc.) or having a Pittsburgh Sleep Quality Index (PSQI) score of 6-11 points. 4: Those who sign the informed consent form and voluntarily accept the intervention methods of this project.

Exclusion criteria

Exclusion criteria: 1: Patients with insomnia disorders who have other diseases that have not been effectively controlled or are extremely severe such as persistent pain caused by various reasons malignant tumors cardiovascular and cerebrovascular diseases neuroendocrine diseases neuromuscular diseases and digestive tract diseases etc. 2: Patients who have mental illnesses or cognitive impairments and are unable to cooperate with medical staff in continuing the investigation and research. 3: Patients who are severely dependent on alcohol sleeping medications and psychiatric medications; 4: Patients with local skin damage at the operation site or those with temperature sensory disorders patients with severe yin deficiency and fire hyperactivity syndrome and those with excessive heat syndrome as well as those who are allergic to ginger juice and moxa smoke. 5: Patients who cannot tolerate moxibustion-related therapies. 6: Pregnant and lactating patients; 7: Patients who are engaged in shift work and have irregular working hours; 8: Patients who have taken other medications that affect sleep within 2 weeks before being enrolled in the study.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index (PSQI);

Secondary

MeasureTime frame
EuroQol Five-Dimension Health Scale (EQ-5D);Indices related to abdominal obesity (body weight, BMI, body fat percentage, basal metabolic rate, waist circumference, hip circumference, waist - to - hip ratio);Generalized Anxiety Disorder Scale (GAD-7);Serum melatonin (MT) level;Beck Depression Inventory-II (BDI-II);Insomnia Severity Index (ISI);Heart rate variability (HRV);

Countries

China

Contacts

Public ContactWei Huang

Hubei Provincial Hospital of Traditional Chinese Medicine

24231637@qq.com13986083982

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026